These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 3602304

  • 1. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H.
    Hunt RD.
    Psychopharmacol Bull; 1987; 23(1):111-4. PubMed ID: 3602304
    [No Abstract] [Full Text] [Related]

  • 2. Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
    Broderick-Cantwell JJ.
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):95-8. PubMed ID: 9893422
    [Abstract] [Full Text] [Related]

  • 3. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [Abstract] [Full Text] [Related]

  • 5. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT.
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [Abstract] [Full Text] [Related]

  • 6. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX, Ma HW, Wan B, Dai XM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A, Richard C, Prinzo R, Binder C.
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [Abstract] [Full Text] [Related]

  • 12. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
    Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, Findling RL.
    J Atten Disord; 2009 Jan; 12(4):308-15. PubMed ID: 18400982
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC, Wan GJ, Kemner JE, Olfson M.
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.
    Sebrechts MM, Shaywitz SE, Shaywitz BA, Jatlow P, Anderson GM, Cohen DJ.
    Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535
    [Abstract] [Full Text] [Related]

  • 20. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.